Genetics In Drug Discovery: The Key To Clinical Trial Success?

Article August 28, 2024

By leveraging human genetics to identify drug targets with a proven link to disease mechanisms, the probability of clinical trial success greatly increases [1].  Only 10% of drugs that enter phase 1 clinical trials eventually make it to market [2], primarily due to issues related to efficacy or safety that arise later on. These frequent […]

DISGENET Academic License: Eligibility, Application & Free Access

Product August 2, 2024

DISGENET is the most extensive and reliable gene-disease association network, providing the latest and most relevant data in the field. It was created by MedBioinformatics, and as an academic or not-for-profit researcher, you can access DISGENET’s core biomedical data at no cost. For deeper insights, we offer additional options utilizing state-of-the-art NLP technology. In this […]

DISGENET Rebrand: A Fresh Look, Same Reliable Data for Tomorrow

News July 8, 2024

DISGENET — our gene-disease association knowledge platform — was created in 2010 driven by our mission that a greater understanding of human genetics was vital to improve people’s health. With over 100,000 web users, we see you agree. Today, that need for reliable, high-quality genomics data hasn’t faltered, but the way we access data has […]

DISGENET: The Next Chapter For Disease Genomics Research

Product June 19, 2024

From today, DisGeNET.org and DISGENET plus will become one unified platform found at disgenet.com. DisGeNET has become a cornerstone for bioinformatics research since starting in 2010. As a small team, we have dedicated 15 years to this valuable resource and we are committed to continuously improving the platform for you, our users. As you can imagine, […]